Mann stated, "We do not expect to realize any material financial benefit from the pending [AccuLynx] transaction in 2025 and have therefore removed any operating results from our 2025 guidance." "We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback